Trademark: 78402515
Status Date
Wednesday, May 31, 2006
Filing Date
Thursday, April 15, 2004
Published for Opposition
Tuesday, January 25, 2005
Abandoned Date
Thursday, April 27, 2006
5 Human blood substitute, namely specialized hemoglobin-cardiovascular pharmaceutical combination to provide super-accelerated oxygen delivery with ultra-fast onset, fluid-sparing and hematocrit-elevating properties; The pharmaceutical treatment is intended for both military and civilian use in field/hospital emergency, surgical or critical care medical services
Jun 1, 2006
Abandonment Notice Mailed - Failure To Respond
May 31, 2006
Abandonment - Failure To Respond Or Late Response
Oct 25, 2005
Correspondence E-Mailed
Oct 25, 2005
Su - Non-Final Action - Written
Oct 13, 2005
Statement Of Use Processing Complete
Sep 30, 2005
Use Amendment Filed
Sep 30, 2005
Teas Statement Of Use Received
Apr 19, 2005
Noa Mailed - Sou Required From Applicant
Jan 25, 2005
Published For Opposition
Jan 5, 2005
Notice Of Publication
Nov 23, 2004
Law Office Publication Review Completed
Nov 22, 2004
Assigned To Lie
Nov 9, 2004
Approved For Pub - Principal Register
Nov 8, 2004
Assigned To Examiner
Apr 23, 2004
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
